Skip to content

PHARMULA

Active Private limited companyfounded 2022active for 4 yearsZoellaan 27A, 3150 HaachtKBO/BCE: BE 0781.819.307

Annual accounts 2025

micro format, filed on 22-06-2026, 39 days before the deadline
€58,361
▲ 0.1%
€57,086
▲ 1.2%
€57,961
▲ 1.5%
€42,614
▼ 0.2%
15.1%
▼ 77.7 percentage points
1.15
▼ 12.58

Balance sheet

balance sheet total €126,721 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

15.1%

Higher than 24% of 10,278 companies in 2025.

1.15

Higher than 33% of 9,860 companies in 2025.

32.9%

Higher than 78% of 10,002 companies in 2025.

PHARMULA Middle half of the sector 80% of the sector Micro accounts in office administrative support (NACE 82)

Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: middle half

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend2025202420232022
Balance sheet: assets
20/58 126,721136,527104,78381,886
21/28 3,0491,1421,8432,162
22/27 3,0491,1421,8432,162
24 4411,1421,8432,162
26 2,609---
29/58 123,671135,385102,94179,724
40/41 20,34433,63639,48914,932
40 20,18410,55815,67414,932
41 16023,07823,8150
54/58 103,093101,74963,45159,040
490/1 235-05,753
Balance sheet: equity and liabilities
10/49 126,721136,527104,78381,886
10/15 19,139126,66784,65749,127
10/11 2,4002,4002,4002,400
14 16,739124,26782,25746,727
17/49 107,5829,85920,12732,759
42/48 107,5829,85920,12732,759
44 4681,0588891,142
440/4 4681,0588891,142
45 4,6358,80119,23823,170
450/3 4,6358,80119,23823,170
454/9 -000
47/48 102,478008,446
Income statement
70 -000
9900 58,36158,31249,00160,298
60/61 -000
630 875701261838
640/8 400-856281
66A -1,209--
9901 57,08656,40247,88559,178
75/76B -1,4216326
75 -1,4216326
65/66B 50749839867
65 50749839867
9903 56,57957,32548,11959,117
67/77 14,84015,31512,59012,390
9904 41,73942,01135,52946,727
9905 41,73942,01135,52946,727
Appropriation of the result
9906 166,007124,26782,25746,727
14P 124,26782,25746,727-
694/7 149,267---
694 149,267---
Document PDFPDFPDFPDF

The notes to these accounts have 5 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 22-06-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 micro format 22-06-2026 2026-00189713 PDF
31-12-2024 micro format 28-08-2025 2025-00427478 PDF
31-12-2023 micro format 30-08-2024 2024-00452514 PDF
31-12-2022 micro format 31-08-2023 2023-00419450 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend2025202420232022
57,96157,10348,14560,016
42,61442,71235,79047,566
2,78202,1033,000
1,34438,2984,411-
16,090125,52682,81446,966
15.1%92.8%80.8%60.0%
1.1513.735.112.43
5.620.080.240.67
218.1%33.2%42.0%95.1%
32.9%30.8%33.9%57.1%
over 100over 100over 100over 100

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item2025202420232022
Tangible fixed assets€2,782€0€2,103€3,000
€875€701€261€838

Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)

Insights on PHARMULA

The operating result for 2025 is 1% higher than in 2024 and the highest since 2022. It is the second rise in a row, after the fall in 2023.

Debt's share of the balance-sheet total rises from 7.2% to 84.9%. Equity is lower and debt is higher.

Next steps